Milnacipran (brand names: Savella, Ixel) is the third and last drug the FDA approved for the treatment of fibromyalgia in the United States. The fourth serotonin–norepinephrine reuptake inhibitor (SNRI), to be introduced in the U.S., Savella stops the reuptake of...
Subscribe
Subscribe To Health Rising’s Free Chronic Fatigue Syndrome, Fibromyalgia and Long COVID Information
